Branded Generics Market

Branded Generics Market: Oncology Therapeutic Application Segment Expected to Grow Significantly in Developed Markets over the Forecast Period: Global Industry Analysis & Opportunity Assessment, 2016 –2026

Increasing prevalence of chronic and lifestyle diseases expected to create demand for branded generics over the assessment period

The global branded generics market was valued at more than US$ 190 Bn in 2015 and is expected to witness a 7.3% CAGR over the forecast period (2016–2026). The market is projected to be valued at more than US$ 410 Bn by 2026. The global branded generics market is expected to represent incremental opportunity of nearly US$ 220 Bn between 2016 and 2026. Rising number of comorbidities like diabetes and cardiovascular diseases is creating ample opportunities for new and existing players in the global branded generics market.

Global Branded Generics Market Value (US$ Bn) By Therapeutic Application, 2016-2026

Cardiovascular diseases application segment expected to hold a large market revenue share over the projected period

The cardiovascular diseases segment was estimated to account for 11.8% market share of the global branded generics market by 2016 end and is expected to gain 102 BPS by 2026 over 2016. Cardiovascular diseases segment is expected to register high Y-o-Y growth throughout the forecast period. The segment was expected to reach a value of nearly US$ 25 Bn by 2016 end and is projected to remain the dominant segment during the forecast period. The dermatology diseases segment is expected to register moderate Y-o-Y growth as compared to other segments throughout the forecast period. Revenue contribution of this segment to the global branded generics market is expected to increase at a CAGR of 6.0% over the forecast period. In terms of value, the cardiovascular diseases segment is expected to register the highest CAGR of 8.2% during the assessment period. The neurology and dermatology diseases segments are expected to remain the least attractive segments in the global branded generics market in revenue terms with an attractive index of 0.5 each over the forecast period.

Diabetes segment market revenue share projected to grow at a significant CAGR owing to increasing prevalence of diabetes in Asia Pacific and MEA regions

The Diabetes segment is estimated to create absolute $ opportunity of US$ 1.6 Bn in 2017 over 2016. Revenue from this segment is projected to witness a CAGR of 7.7% from 2016 to 2026 to reach a value of nearly US$ 45 Bn by 2026. The Oncology segment is estimated to create absolute $ opportunity of US$ 1.1 Bn in 2017 over 2016. Revenue from this segment is projected to exhibit a CAGR of 6.9% from 2016 to 2026 to reach a value of more than US$ 30 Bn by 2026. The Neurology segment is estimated to create absolute $ opportunity of US$ 0.8 Bn in 2017 over 2016. Revenue from this segment is projected to register a CAGR of 6.1% from 2016 to 2026 to reach a value of about US$ 25.0 Bn by 2026. The Analgesics and Anti-inflammatory segment is estimated to create absolute $ opportunity of US$ 0.9 Bn in 2017 over 2016. Revenue from this segment is projected to witness a CAGR of 6.6% from 2016 to 2026 to reach a value of nearly US$ 30 Bn by 2026.

branded generics market_Image for preview analysis

Increasing out-of-pocket healthcare expenditure and patent expiries of blockbuster drugs fuelling the global branded generics market

As per Future Market Insights analysis, emerging economics such as Brazil, Russia, India and China are the most lucrative markets for branded generics. A big aspect that is fuelling the global branded generics market is the increasing out-of-pocket expenditure on healthcare in both emerging and developed economies. In addition, patent expiries of blockbuster drugs is also positively impacting the global branded generics market. Analysts working on this report have noticed a trend of mergers and acquisitions amongst the key market players to help consolidate their position in the global branded generics market. 

Future Market Insights presents an insightful analysis of branded generics in the global market in its new publication titled ‘Branded Generics Market: Global Industry Analysis and Opportunity Assessment, 2016–2026’. In this report, Future Market Insights has focussed on presenting a global market outlook and the main aim of this report is to offer a clear picture on the market opportunities in the global branded generics market over a forecast period of ten years, 2016-2026. In this report, we have included an in-depth analysis of the key trends, drivers and restraints from the supply and demand perspectives to gain a comprehensive understanding of the global branded generics market. In addition, impact analysis of key growth drivers and restraints based on the weighted average model is also included in the report to help clients take important decisions based on our broad ranging analysis.

Report description

The primary objective of the report is to offer insights on the market dynamics that can influence revenue growth of the global branded generics market over the forecast period. Insights on key trends, drivers, restraints, value forecasts and opportunities for companies operating in the global branded generics market are presented in the report. To understand and assess opportunities in this market, the report offers market forecast on the basis of therapeutic application, drug class, formulation type, distribution channel and regions. The report provides analysis of the global branded generics market in terms of market value (US$ Mn).

Market segmentation

By Formulation Type

By Therapeutic Application

By Drug Class

By Distribution Channel

By Region

  •  Oral

  •  Parenteral

  • Topical

  • Others

 

  •  Oncology

  •  Cardiovascular Diseases

  •  Diabetes

  •  Neurology

  •  Gastrointestinal Diseases

  •  Dermatology Diseases

  •  Analgesics and Anti-inflammatory

  •  Others

  •  Alkylating Agents

  •  Antimetabolites

  •  Hormones

  •  Anti-Hypertensive

  •  Lipid Lowering Drugs

  •  Anti-Depressants

  •  Anti-Psychotics

  •  Anti-Epileptics

  •  Others

  •  Hospital Pharmacies

  •  Retail Pharmacies

  •  Online Pharmacies

  •  Drug Stores

 

  •  North America

  •  Latin America

  •  Western Europe

  •  Eastern Europe

  •  APEJ

  •  MEA

  •  Japan

The report begins with the market definition followed by definitions of the different therapeutic applications, drug classes, and formulation types. The market dynamics section includes Future Market Insights’ analysis on key trends, drivers, restraints, opportunities and macro-economic factors influencing the growth of the global branded generics market. The next section of the report analyses the market on the basis of drug class and therapeutic application and presents a revenue forecast for the next 10 years. The report then analyses the market on the basis of formulations and presents a forecast in terms of value for the next 10 years. The report further analyses the market on the basis of distribution channel and presents a forecast in terms of value for the next 10 years. Next, the report analyses the market on the basis of various regions and presents a forecast in terms of value for the next 10 years.

In the final section of the report, a ‘competitive landscape’ has been included to provide a dashboard view of key companies operating in the global branded generics market. This section is primarily designed to provide clients with an objective and detailed comparative assessment of key providers specific to a market segment in the global branded generics market and the potential players. This section also includes market strategies and SWOT analysis of the main players operational in the global branded generics market. Detailed profiles of branded generics manufacturers are also included in the scope of the report to evaluate their long- and short-term strategies.

Research methodology

In order to arrive at the market size of the global branded generics market, we have considered various viewpoints based on secondary research. Furthermore, data points such as regional split and market split by segmentation and qualitative inputs from industry experts have been considered to arrive at suitable market estimates. The forecast presented in the report evaluates the actual revenue generated and expected revenue in the global branded generics market over the forecast period. We have analysed the massive amount of data gathered through primary and secondary research and validated it using different methods such as the triangulation method and also scrutinised the data using advanced tools to present deep insights into the global branded generics market.

Stand out metrics included in the report

We have included several key metrics in our report to give solid figures that support our assumptions and assertions of the global branded generics market. Given the ever-fluctuating nature of the global economy, we not only conduct forecasts in terms of CAGR, but also analyse the market on the basis of key parameters such as year-on-year (Y-o-Y) growth to understand the predictability of the market and to pinpoint the right opportunities in the global branded generics market. As previously highlighted, the global market for branded generics is segmented into different categories. All these categories have been analysed in terms of Basis Point Share (BPS) to understand the individual segments’ relative contribution to market growth. This detailed level of information is important for identification of many key trends governing the global branded generics market. Last but not the least, in order to understand the key market segments in terms of growth and performance of the global branded generics market, we have developed a unique market attractiveness index to help clients identify real market opportunities.